Mark Yarchoan Net Worth (Estimated)
Founder at Adventris Pharmaceuticals · YC W23
Quick answer
Mark Yarchoan's estimated net worth / paper wealth is $6.7M (range $4.7M–$10.0M) as of 2026.
Mark Yarchoan is Founder at Adventris Pharmaceuticals (YC W23). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: University of Pennsylvania
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 7
- Website: https://adventris.com
Who is Mark Yarchoan?
Mark Yarchoan is a founder involved with Adventris Pharmaceuticals and has participated in Y Combinator's Winter 2023 batch.
Highlights:
- University of Pennsylvania
- Adventris Pharmaceuticals
- Y Combinator W23
About Adventris Pharmaceuticals
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths.
If you are interested in learning more about our approach to treat and prevent...
Model inputs
- Stage: seed
- Valuation tier: fallback-seed
- Valuation note: no_discovery_sources
- Research as-of: 2026-08-04
- Funding input: no public raise amount found; stage fallback valuation
FAQ: Mark Yarchoan net worth and Adventris Pharmaceuticals valuation
What is Mark Yarchoan's net worth?
Mark Yarchoan's estimated net worth / paper wealth is $6.7M (range $4.7M–$10.0M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.
Mark Yarchoan net worth
Mark Yarchoan's estimated net worth / paper wealth is $6.7M (range $4.7M–$10.0M) as of 2026. This Mark Yarchoan net worth figure is estimated paper wealth, not a verified statement of assets.
How much is Mark Yarchoan worth?
Mark Yarchoan's estimated net worth / paper wealth is $6.7M (range $4.7M–$10.0M) as of 2026. How much Mark Yarchoan is worth here means estimated paper wealth from public company and role data — not financial advice.
How rich is Mark Yarchoan?
Mark Yarchoan's estimated net worth / paper wealth is $6.7M (range $4.7M–$10.0M) as of 2026. “How rich is Mark Yarchoan” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.
Mark Yarchoan fortune
Mark Yarchoan's estimated net worth / paper wealth is $6.7M (range $4.7M–$10.0M) as of 2026. This Mark Yarchoan fortune figure is estimated paper wealth only, not a verified statement of assets.
Mark Yarchoan equity value
Mark Yarchoan's estimated net worth / paper wealth is $6.7M (range $4.7M–$10.0M) as of 2026. Mark Yarchoan equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.
What is Adventris Pharmaceuticals valuation?
Adventris Pharmaceuticals's estimated valuation on Entrepreneurial Check is $20.0M. Independent model output, not a verified appraisal or official mark.
What is Adventris Pharmaceuticals post-money valuation?
Adventris Pharmaceuticals's estimated valuation on Entrepreneurial Check is $20.0M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.
What is Adventris Pharmaceuticals funding?
Adventris Pharmaceuticals funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Adventris Pharmaceuticals raised is not a complete cap table — figures are estimates only.
How much did Adventris Pharmaceuticals raise?
How much Adventris Pharmaceuticals raised, when disclosed, informs the estimated Adventris Pharmaceuticals valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.
How much money did Adventris Pharmaceuticals raise?
How much money Adventris Pharmaceuticals raised, when a public figure is available, is a model input for the estimated Adventris Pharmaceuticals valuation on this profile. Estimates only — not a complete cap table.
What is Adventris Pharmaceuticals series funding?
Adventris Pharmaceuticals series funding, when a public raise is disclosed, informs the estimated Adventris Pharmaceuticals valuation here. Not a complete financing history.
What company is Mark Yarchoan building?
Mark Yarchoan is Founder at Adventris Pharmaceuticals, a Y Combinator-backed startup (batch W23).
What YC batch is Mark Yarchoan from?
Mark Yarchoan is associated with Y Combinator batch W23.
Where did Mark Yarchoan go to school?
Public profiles associate Mark Yarchoan with University of Pennsylvania.
What other companies is Mark Yarchoan connected to?
Public associations for Mark Yarchoan include Adventris Pharmaceuticals.
Where is Mark Yarchoan based?
Public directory data lists Mark Yarchoan's region as United States of America.
What industry is Mark Yarchoan in?
Mark Yarchoan is listed under Healthcare, Drug Discovery and Delivery.
How big is Adventris Pharmaceuticals?
Public data lists Adventris Pharmaceuticals's team size as 7.
What else is notable about Mark Yarchoan?
University of Pennsylvania.
Is Entrepreneurial Check affiliated with Y Combinator?
No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.